Inhibition of mutationally activated HER2
- 27 August 2022
- journal article
- research article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 101 (1) , 87-102
Abstract
Human epidermal growth factor receptor 2 (HER2) is an oncogenic driver and key therapeutic target for human cancers. Current therapies targeting HER2 are primarily based on overexpression of the wild‐type form of HER2. However, kinase domain mutations have been identified that can increase the activity of HER2 even when expressed at basal levels. Using purified enzymes, we confirmed the hyperactivity of two HER2 mutants (D769Y and P780insGSP). To identify small molecule inhibitors against these cancer‐associated variants, we used a combined approach consisting of biochemical testing, similarity‐based searching, and in silico modeling. These approaches resulted in the identification of a candidate molecule that inhibits mutant forms of HER2 in vitro and in cell‐based assays. Our structural model predicts that the compound takes advantage of water‐mediated interactions in the HER2 kinase binding pocket.Keywords
Funding Information
- National Institutes of Health
- U.S. Department of War
- U.S. Department of Veterans Affairs
This publication has 70 references indexed in Scilit:
- Differences in the Binding Affinities of ErbB Family: Heterogeneity in the Prediction of Resistance MutantsPLOS ONE, 2013
- ChemMine tools: an online service for analyzing and clustering small moleculesNucleic Acids Research, 2011
- Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 ProteinJournal of Biological Chemistry, 2011
- Docking Validation Resources: Protein Family and Ligand Flexibility ExperimentsJournal of Chemical Information and Modeling, 2010
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- Mechanism of Activation and Inhibition of the HER4/ErbB4 KinaseStructure, 2008
- An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor ReceptorCell, 2006
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Structure of the extracellular region of HER2 alone and in complex with the Herceptin FabNature, 2003
- Comparison of simple potential functions for simulating liquid waterThe Journal of Chemical Physics, 1983